Patents by Inventor Mark Dennis

Mark Dennis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8691531
    Abstract: The present invention is directed to compositions of matter comprising nucleic acids encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 207 or 208, encoding an anti-CD79b antibody comprising the heavy chain variable domain sequence of SEQ ID NO: 207 and the light chain variable domain sequence of SEQ ID NO: 208, or encoding an anti-CD79b antibody having : (i) a variable light chain comprising a HVR-L1 having the sequence of SEQ ID NO: 194, a HVR-L2 having the sequence of SEQ ID NO: 195, and a HVR-L3 having the sequence of SEQ ID NO: 196 and (ii) a variable light chain comprising a HVR-H1 having the sequence of SEQ ID NO: 202, a HVR-H2 having the sequence of SEQ ID NO: 203, and a HVR-H3 having the sequence of SEQ ID NO: 204, and vectors and host cells thereof.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: April 8, 2014
    Assignee: Genentech, Inc.
    Inventors: Yvonne Chen, Mark Dennis, David Dornan, Kristi Elkins, Jagath Reddy Junutula, Andrew Polson, Bing Zheng
  • Publication number: 20140080152
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: August 9, 2013
    Publication date: March 20, 2014
    Applicant: Genentech, Inc.
    Inventors: Mark Dennis, Bonnee Rubinfeld, Paul Polakis
  • Publication number: 20140079721
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: August 9, 2013
    Publication date: March 20, 2014
    Applicant: Genentech, Inc.
    Inventors: Mark Dennis, Bonnee Rubinfeld, Paul Polakis
  • Patent number: 8675650
    Abstract: A technique is disclosed for synchronizing NAT information stored on different network devices that have been configured to implement a network address translation protocol. Each of the network devices includes a respective NAT data structure configured to store NAT information. The NAT information includes at least one NAT entry relating to a network node engaged in a communication session with at least one other network node. At least one NAT entry in a first NAT data structure is modified. The first NAT data structure is associated with a first NAT network device. A first NAT transaction message is generated which includes information relating to the modifications performed on the first NAT data structure. The first NAT transaction message is transmitted to at least one other NAT network device to thereby cause that device to modify its respective NAT data structure using information from the first NAT transaction message.
    Type: Grant
    Filed: January 10, 2011
    Date of Patent: March 18, 2014
    Assignee: Cisco Technology, Inc.
    Inventors: Siva S. Jayasenan, Mike Sullenberger, Mark Denny, Murali Venkateshaiah
  • Publication number: 20140050744
    Abstract: The invention is directed to antibody drug conjugate compositions of matter useful for the diagnosis and treatment of tumors in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: July 18, 2013
    Publication date: February 20, 2014
    Inventors: Mark Dennis, William Mallet, Paul Polakis
  • Publication number: 20140037624
    Abstract: The invention provides anti-FGFR4 antibodies and methods of using the same.
    Type: Application
    Filed: October 4, 2013
    Publication date: February 6, 2014
    Applicant: GENENTECH, INC.
    Inventors: Mark Dennis, Luc Desnoyer, Dorothy French
  • Patent number: 8641827
    Abstract: A cleaning composition includes water, glycerine, at least one alkyl polyglycoside and a surface modification polymer. The surface modification polymer acts to provides for initial cleaning or pretreatment of the hard surface and provides a hydrophilic coating or barrier layer on the surface which provides residual cleaning to the hard surface for an extended number of cleanings. The composition has an alkaline pH of from about 8 to 10.
    Type: Grant
    Filed: October 29, 2012
    Date of Patent: February 4, 2014
    Assignee: Ecolab USA Inc.
    Inventors: Amanda Ruth Blattner, Charles Allen Hodge, Erin Jane Dahlquist, Mark Dennis Levitt
  • Patent number: 8632775
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: January 21, 2014
    Assignee: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andrew Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • Publication number: 20140011981
    Abstract: The invention provides an expression and secretion system, and methods of using the same, for the expression and secretion of one fusion protein in prokaryotic cells and a second fusion protein in eukaryotic cells. Also provided herein are nucleic acid molecules, vectors and host cells comprising such vectors and nucleic acid molecules.
    Type: Application
    Filed: July 3, 2013
    Publication date: January 9, 2014
    Applicant: GENENTECH, INC.
    Inventors: Devin Tesar, Xiaocheng Chen, Mark Dennis, Isidro Hotzel
  • Patent number: 8617317
    Abstract: Renewable, non-volatile cleaning compositions incorporating ethyl ester solvents are disclosed. Preferred compositions employ non-volatile C8-16 ethyl ester solvents. All-purpose cleaning compositions incorporating the non-volatile C8-16 ethyl ester solvents, further include an alkyl polyglycoside surfactant, an alcohol ethoxylate surfactant, and water. Preferably the compositions are free of anionic, cationic and amphoteric surfactants and/or co-solvents. The invention also discloses methods employing the non-volatile solvent all-purpose cleaning compositions.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: December 31, 2013
    Assignee: Ecolab USA Inc.
    Inventor: Mark Dennis Levitt
  • Patent number: 8618274
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: December 31, 2013
    Assignee: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andy Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • Publication number: 20130344469
    Abstract: An interactive networked classroom system including a teacher workstation with a base application, and one or more code segments. Each code segment includes a teacher version and a student version. The code segments include API links to a base application at the teacher workstation, or to helper functions such as plug-ins to the base application, such that the student version of the code segment has different rights, typically fewer and less powerful rights, than the teacher version of the same code segment. The teacher workstation forwards the student version of a code segment to student workstations that are in communication with the teacher workstation over a network facility; the student code segments may be embedded in a document corresponding to a classroom activity. Interactive classroom activities are then carried out using the code segments in combination with the base application.
    Type: Application
    Filed: June 25, 2013
    Publication date: December 26, 2013
    Inventors: Albert Louis Abrahamson, Corey Brady, Robert C.W. Jenks, Mark Dennis Fry, Todd M. Wostrel
  • Patent number: 8586040
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: November 19, 2013
    Assignee: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andy Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • Patent number: 8565768
    Abstract: A mobile telecommunications system comprises a network of a plurality of cells and at least one user equipment device operable to communicate in the system and to operate in a first RAT and a second RAT. The method comprises, in the user equipment device, determining whether the validity of data stored on the user equipment device will expire within an expiry period, the stored data being for use in handover of operation of the user equipment device from the first RAT to the second RAT.
    Type: Grant
    Filed: July 12, 2011
    Date of Patent: October 22, 2013
    Assignee: BlackBerry Limited
    Inventors: Andrew Farnsworth, Mark Dennis Norton, Gideon Roberts
  • Publication number: 20130266921
    Abstract: A method for operating a classroom network including a host computer and a plurality of digital devices communicatively coupled to the host computer is provided. The method includes receiving student responses by the host computer from the plurality of digital devices over a period of time, wherein the student responses are generated while performing a class activity on each digital device, storing the student responses as the student responses are received, and replaying a user selected portion of the stored student responses on the host computer, wherein the replayed student responses are displayed according to a first user specified analysis view.
    Type: Application
    Filed: April 4, 2012
    Publication date: October 10, 2013
    Inventors: Robert Charles Wellman Jenks, Corey Edison Brady, Mark Dennis Fry, Albert Louis Abrahamson
  • Patent number: 8545850
    Abstract: The present invention is directed to compositions of matter comprising immunoconjugates comprising an anti-CD79b antibody comprising: (i) an HVR-L1 sequence of KASQSVDYEGDSFLN (SEQ ID NO: 194), (ii) an HVR-L2 sequence of AASNLES (SEQ ID NO: 195), (iii) an HVR-L3 sequence of QQSNEDPLT (SEQ ID NO: 196), (iv) an HVR-H1 sequence of GYTFSSYWIE (SEQ ID NO: 202), (v) an HVR-H2 sequence of GEILPGGGDTNYNEIFKG (SEQ ID NO: 203), and (vi) an HVR-H3 sequence of TRRVPIRLDY (SEQ ID NO: 204) and to methods of using those compositions of matter for the treatment of hematopoietic tumor in mammals.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: October 1, 2013
    Assignee: Genentech, Inc.
    Inventors: Yvonne Chen, Mark Dennis, David Dornan, Kristi Elkins, Jagath Reddy Junutula, Andrew Polson, Bing Zheng
  • Patent number: 8535675
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: November 30, 2010
    Date of Patent: September 17, 2013
    Assignee: Genentech, Inc.
    Inventors: Mark Dennis, Bonnee Rubinfeld, Paul Polakis
  • Patent number: 8472996
    Abstract: A method and apparatus for calculating an initial transmission power in a mobile telecommunications system is disclosed, the system comprising a network of a plurality of cells and at least one user equipment device. The user equipment device receives broadcast system information, and measures a signal power. An initial transmission power is calculated in a lowest logical layer of the system defined as a protocol stack, using the received information and measured power.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: June 25, 2013
    Assignee: Research In Motion Limited
    Inventors: Andrew John Farnsworth, Mark Dennis Norton
  • Publication number: 20130149237
    Abstract: The invention provides shuttle agents and methods of using the same to facilitate the translocation of therapeutic or diagnostic molecules into the CNS.
    Type: Application
    Filed: January 21, 2011
    Publication date: June 13, 2013
    Applicants: GENENTECH, INC., F. HOFFMANN-LA ROCHE AG
    Inventors: Mark Dennis, Per-Ola Freskgard, Stephen Tam, Ryan Watts, Joy Yu
  • Publication number: 20130126634
    Abstract: The present invention relates to a solid pressed air freshener and odor neutralizer composition which can include greater than 10% fragrance. The air freshener comprises a fragrance; preferably the fragrance is impregnated within a water soluble substrate made from a foamed vegetable starch, a surfactant and a solidifier. The solid formulations break down easily in the presence of water and may be sprayed, within the area to be freshened.
    Type: Application
    Filed: November 22, 2011
    Publication date: May 23, 2013
    Applicant: ECOLAB USA INC.
    Inventors: Amanda Ruth Blattner, Charles Allen Hodge, Timothy John Kohnke, Mark Dennis Levitt, Julie Ellen Marquardt